Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label; single-arm; multicentre; phase 2 study.

Tiede A; Hart C; Knöbl P; Greil R; Oldenburg J; Sachs UJ; Miesbach W; Pfrepper C; Trautmann-Grill K; Holstein K; Pilch J; Möhnle P; Schindler C; Weigt C; Schipp D; May M; Dobbelstein C; Pelzer FJ; Werwitzke S; Klamroth R.

Lancet Haematol. 2023 Nov;10(11):e913-e921.  doi: 10.1016/S2352-3026(23)00280-6. Epub 2023 Oct 16.

https://pubmed.ncbi.nlm.nih.gov/37858328/